{"id":2713,"date":"2019-06-04T15:40:24","date_gmt":"2019-06-04T13:40:24","guid":{"rendered":"https:\/\/biologika-register.de\/?page_id=2713"},"modified":"2019-06-04T16:13:40","modified_gmt":"2019-06-04T14:13:40","slug":"rekrutierung","status":"publish","type":"page","link":"https:\/\/biologika-register.de\/en\/rekrutierung\/","title":{"rendered":"Recruitment"},"content":{"rendered":"\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Eingeschlossene Patienten: 24.086 (Stand 02. April 2026)<\/th><\/td>\n<\/tr>\n<\/thead>\n
Amgevita\u00ae (Adalimumab)<\/td>278<\/td>\n<\/tr>\n
Avtozma\u00ae (Tocilizumab)<\/td>1<\/td>\n<\/tr>\n
Benepali\u00ae (Etanercept)<\/td>1344<\/td>\n<\/tr>\n
Cimzia\u00ae (Certolizumab)<\/td>1070<\/td>\n<\/tr>\n
Enbrel\u00ae (Etanercept)<\/td>2882<\/td>\n<\/tr>\n
Erelzi\u00ae (Etanercept)<\/td>647<\/td>\n<\/tr>\n
Flixabi\u00ae (Infliximab)<\/td>10<\/td>\n<\/tr>\n
Hukyndra\u00ae (Adalimumab)<\/td>27<\/td>\n<\/tr>\n
Hulio\u00ae (Adalimumab)<\/td>330<\/td>\n<\/tr>\n
Humira\u00ae (Adalimumab)<\/td>2912<\/td>\n<\/tr>\n
Hyrimoz\u00ae (Adalimumab)<\/td>310<\/td>\n<\/tr>\n
Idacio\u00ae (Adalimumab)<\/td>77<\/td>\n<\/tr>\n
Imraldi\u00ae (Adalimumab)<\/td>264<\/td>\n<\/tr>\n
Inflectra\u2122 (Infliximab)<\/td>16<\/td>\n<\/tr>\n
Jyseleca\u00ae (Filgotinib)<\/td>211<\/td>\n<\/tr>\n
Kevzara\u00ae (Sarilumab)<\/td>251<\/td>\n<\/tr>\n
Kineret\u00ae (Anakinra)<\/td>89<\/td>\n<\/tr>\n
MabThera\u00ae (Rituximab)<\/td>1459<\/td>\n<\/tr>\n
Nepexto\u00ae (Etanercept)<\/td>131<\/td>\n<\/tr>\n
Olumiant\u00ae (Baricitinib)<\/td>570<\/td>\n<\/tr>\n
Orencia\u00ae (Abatacept)<\/td>1003<\/td>\n<\/tr>\n
Remicade\u00ae (Infliximab)<\/td>762<\/td>\n<\/tr>\n
Remsima\u00ae (Infliximab)<\/td>27<\/td>\n<\/tr>\n
Rinvoq\u00ae (Upadacitinib)<\/td>375<\/td>\n<\/tr>\n
Rixathon\u00ae (Rituximab)<\/td>20<\/td>\n<\/tr>\n
RoActemra\u00ae (Tocilizumab)<\/td>1385<\/td>\n<\/tr>\n
Ruxience\u00ae (Rituximab)<\/td>1<\/td>\n<\/tr>\n
Simponi\u00ae (Golimumab)<\/td>486<\/td>\n<\/tr>\n
Truxima\u00ae (Rituximab)<\/td>9<\/td>\n<\/tr>\n
Tyenne\u00ae (Tocilizumab)<\/td>84<\/td>\n<\/tr>\n
Xeljanz\u00ae (Tofacitinib)<\/td>406<\/td>\n<\/tr>\n
Yuflyma\u00ae (Adalimumab)<\/td>93<\/td>\n<\/tr>\n
Zessly\u00ae (Infliximab)<\/td>2<\/td>\n<\/tr>\n
Kontrollen<\/td>6554<\/td>\n<\/tr>\n
<\/td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_crdt_document":"","generate_page_header":"","footnotes":""},"class_list":{"0":"post-2713","1":"page","2":"type-page","3":"status-publish","5":"infinite-scroll-item"},"_links":{"self":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/2713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/comments?post=2713"}],"version-history":[{"count":3,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/2713\/revisions"}],"predecessor-version":[{"id":2718,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/2713\/revisions\/2718"}],"wp:attachment":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/media?parent=2713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}